Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices.

作者: George E. Davis , Kayla J. Bayless , Anil Mavila

DOI: 10.1002/AR.10159

关键词:

摘要: Although many studies have focused on blood vessel development and new formation associated with disease processes, the question of how endothelial cells (ECs) assemble into tubes in three dimensions (i.e., EC morphogenesis) remains unanswered. morphogenesis is particularly dependent a signaling axis involving extracellular matrix (ECM), integrins, cytoskeleton, which regulates shape changes signals pathways necessary for tube formation. Recent reveal that genes regulating this matrix-integrin-cytoskeletal (MIC) are differentially expressed during morphogenesis. The Rho GTPases represent an important class molecules involved these events. Cdc42 Rac1 required process intracellular vacuole coalescence lumen three-dimensional (3D) matrices, while RhoA appears to stabilize capillary networks. Once networks established, supporting cells, such as pericytes, recruited further networks, perhaps by basement membrane assembly. Furthermore, we consider recent work showing balanced tendency newly formed regress. This morphogenesis-regression balance controlled differential gene expression VEGF, angiopoietin-2, PAI-1, well plasmin- metalloproteinase-dependent mechanism induces regression through degradation ECM scaffolds support EC-lined tubes. It our hope review will stimulate increased interest effort basic mechanisms 3D matrices.

参考文章(242)
Khalid Bajou, Véronique Masson, Robert D. Gerard, Petra M. Schmitt, Valérie Albert, Michael Praus, Leif R. Lund, Thomas L. Frandsen, Nils Brunner, Keld Dano, Norbert E. Fusenig, Ulrich Weidle, Geert Carmeliet, David Loskutoff, Desiré Collen, Peter Carmeliet, Jean Michel Foidart, Agnès Noël, The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies Journal of Cell Biology. ,vol. 152, pp. 777- 784 ,(2001) , 10.1083/JCB.152.4.777
Themis R. Kyriakides, Yu-Hong Zhu, Lynne T. Smith, Steven D. Bain, Zhantao Yang, Ming T. Lin, Keith G. Danielson, Renato V. Iozzo, Mary LaMarca, Cindy E. McKinney, Edward I. Ginns, Paul Bornstein, Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis Journal of Cell Biology. ,vol. 140, pp. 419- 430 ,(1998) , 10.1083/JCB.140.2.419
Joshua H. Lipschutz, Wei Guo, Lucy E. O'Brien, Yen H. Nguyen, Peter Novick, Keith E. Mostov, Exocyst is involved in cystogenesis and tubulogenesis and acts by modulating synthesis and delivery of basolateral plasma membrane and secretory proteins. Molecular Biology of the Cell. ,vol. 11, pp. 4259- 4275 ,(2000) , 10.1091/MBC.11.12.4259
William B. Kiosses, R. Hugh Daniels, Carol Otey, Gary M. Bokoch, Martin Alexander Schwartz, A role for p21-activated kinase in endothelial cell migration. Journal of Cell Biology. ,vol. 147, pp. 831- 844 ,(1999) , 10.1083/JCB.147.4.831
S. Kamada, H. Kusano, H. Fujita, M. Ohtsu, R. C. Koya, N. Kuzumaki, Y. Tsujimoto, A cloning method for caspase substrates that uses the yeast two-hybrid system: Cloning of the antiapoptotic gene gelsolin Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 8532- 8537 ,(1998) , 10.1073/PNAS.95.15.8532
Michael S. Pepper, Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 21, pp. 1104- 1117 ,(2001) , 10.1161/HQ0701.093685
Joseph A. Madri, Sepi Mahooti, Neta Ilan, Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis Journal of Cell Science. ,vol. 111, pp. 3621- 3631 ,(1998) , 10.1242/JCS.111.24.3621
Luc De Vries, Bin Zheng, Thierry Fischer, Eric Elenko, Marilyn G. Farquhar, The regulator of G protein signaling family. Annual Review of Pharmacology and Toxicology. ,vol. 40, pp. 235- 271 ,(2000) , 10.1146/ANNUREV.PHARMTOX.40.1.235